本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

The Oncology Institute

2.52
+0.08003.28%
盘后2.520.00000.00%16:46 EDT
成交量:81.30万
成交额:201.87万
市值:2.27亿
市盈率:-3.61
高:2.54
开:2.45
低:2.40
收:2.44
数据加载中...
2022/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/17

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/12/14

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/12/14

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/12/09

重要事件披露

8-K - Current report
2021/11/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/22

重要事件披露

8-K/A [Amend] - Current report
2021/11/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/18

重要事件披露

8-K - Current report
2021/11/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/11/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

重要事件披露

8-K - Current report